Holen Sie sich die Stockscreener-App
39.65
4.39%
-1.82
Finanzdaten der Spruce Biosciences Inc-Aktie (SPRB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
37.75%
16.51
|
11.99 | 11.10 | 8.229 | 2.692 |
| Interest Income/Expense |
62.76%
1.097
|
0.674 | 0.006 | 0.019 | 0.029 |
| Depreciation and Amortization |
150.40%
0.631
|
0.252 | 0.005 | 0.003 | 0.007 |
| Operating Income/Loss |
37.75%
-16.51
|
-11.99 | -11.10 | -8.229 | -2.692 |
| Net Income/Loss |
32.31%
-16.23
|
-12.27 | -14.65 | -8.212 | -2.067 |
| Basic Average Shares |
77.18%
2.4311
|
1.3721 | 0.1771 | 0.5631 | 0.5911 |
| Diluted Average Shares |
77.18%
2.4311
|
1.3721 | 0.1771 | 0.5631 | 0.5911 |
| Basic Earnings Per Share |
25.28%
-6.68
|
-8.94 | -9.58 | -14.58 | -3.50 |
| Diluted Earnings Per Share |
25.28%
-6.68
|
-8.94 | -9.58 | -14.58 | -3.50 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):